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T

he nonhomologous end-joining (NHEJ) pathway
is essential for radioresistance and lymphocytespecific V(D)J (variable [diversity] joining) recombination. Defects in NHEJ also impair hematopoietic stem
cell (HSC) activity with age but do not affect the initial
establishment of HSC reserves. In this paper, we report that,
in contrast to deoxyribonucleic acid (DNA)–dependent
protein kinase catalytic subunit (DNA-PKcs)–null mice,
knockin mice with the DNA-PKcs3A/3A allele, which codes
for three alanine substitutions at the mouse Thr2605 phosphorylation cluster, die prematurely because of congenital
bone marrow failure. Impaired proliferation of DNAPKcs3A/3A HSCs is caused by excessive DNA damage and

p53-dependent apoptosis. In addition, increased apoptosis in the intestinal crypt and epidermal hyperpigmentation indicate the presence of elevated genotoxic stress and
p53 activation. Analysis of embryonic fibroblasts further
reveals that DNA-PKcs3A/3A cells are hypersensitive to
DNA cross-linking agents and are defective in both
homologous recombination and the Fanconi anemia DNA
damage response pathways. We conclude that phosphory
lation of DNA-PKcs is essential for the normal activation
of multiple DNA repair pathways, which in turn is critical
for the maintenance of diverse populations of tissue stem
cells in mice.

Introduction
DNA double-stranded breaks (DSBs) are among the most dangerous forms of DNA damage. Unrepaired DSBs signal cells
to die, whereas misprocessing of DSBs can lead to genomic
instability and oncogenic transformation. DSBs are primarily repaired by the nonhomologous end-joining (NHEJ) and
homologous recombination (HR) repair pathways. The NHEJ
pathway joins the two ends of a DSB directly with little or no
requirement for homology, whereas HR uses the intact identical
Correspondence to Benjamin P.C. Chen: benjamin.chen@utsouthwestern.edu
Abbreviations used in this paper: ATM, ataxia telangiectasia mutated; ATR, ATM
and Rad3 related; BMT, bone marrow transplantation; DNA-PK, DNA-dependent protein kinase; DNA-PKcs, DNA-PK catalytic subunit; DR, direct repeat;
DSB, double-stranded break; ES, embryonic stem; FA, Fanconi anemia; GR,
glucocorticoid receptor; HR, homologous recombination; HSC, hematopoietic
stem cell; IR, ionizing radiation; MEF, mouse embryonic fibroblast; MMC, mitomycin C; NHEJ, nonhomologous end joining; SCID, severe combined immunodeficiency; tACE, testes-specific angiotensin-converting enzyme.
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copy of the broken chromosome as a template. Although both
NHEJ and HR proteins are recruited to DSBs, pathway choice
is regulated in part by the cell cycle phase, with HR being active
in S/G2 and NHEJ contributing to DSB repair predominantly
in G0/G1. For example, V(D)J (variable [diversity] joining)
recombination-associated breaks are generated in G0/G1 and
resolved by NHEJ proteins, whereas meiotic DSBs are processed by HR proteins. Nevertheless, a recent study indicates
competition between HR and NHEJ for replication- and ionizing radiation (IR)–induced DSBs during the S and G2 phase of
the cell cycle (Sonoda et al., 2006).
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Results
Generation of a DNA-PKcs3A knockin
mouse model

Our knockin mouse model of DNA-PKcs harbors three alanine
substitutions at Thr2605, Thr2634, and Thr2643 (3A mutation,
corresponding to human Thr2609, Thr2638, and Thr2647) of the
endogenous mouse DNA-PKcs or PRKDC gene locus (Fig. 1 A).
The design of the 3A knockin targeting vector was based on a
previously described self-excision ACN (testes-specific angiotensin-converting enzyme [tACE]–Cre/neomycin [Neo]) cassette
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Figure 1. Generation of a DNA-PKcs3A/3A knockin mouse model. (A) The
alignment of the human Thr2609 and the mouse Thr2605 phosphorylation
cluster of DNA-PKcs. Six phosphorylation sites were identified in the human
Thr2609 cluster (highlighted with asterisks), which are highly conserved in
the mouse except for Ser2624. Boxes indicate the positions of knockin mutations or alanine substitutions. (B) Strategy to introduce knockin mutations
into a mouse ES cell. 58*, exon 58 with T2605A, T2634A, and T2643A
mutations; tACE-Cre, Cre recombinase driven by a tACE promoter.
(C) 3A mutation does not alter the expression of DNA-PKcs. Whole-cell
lysates from different MEFs were analyzed for the expression of DNA-PKcs,
Ku70/80, and -actin. (D) DNA-PKcs3A/3A MEFs are hypersensitive to
radiation (representative of three independent assays). Error bars represent
SD. (E) Survival curves generated by Kaplan–Meier analysis (curves were
compared using log-rank test).

strategy (Bunting et al., 1999). The ACN cassette, including a
testes-specific tACE promoter-driven Cre recombinase, a Neoselectable marker, and two flanking loxP sites, was fused with
two genomic fragments with the longer fragment carrying mutated exon 58 (covering the entire mouse Thr2605 cluster) in
close proximity to the ACN cassette (Fig. 1 B). Upon successful
gene targeting and subsequent germline transmission in chimeric mice, expression of Cre recombinase during spermatogenesis
self-excises the ACN cassette. This process leaves behind one
remaining loxP site and allows the expression of the 3A mutant
DNA-PKcs from the targeted allele. Using this strategy, two
knockin mouse lines were generated from two independently
targeted embryonic stem (ES) cell clones. Analyses of mice and
cultured cells yielded identical phenotypes from both lines.
Alanine substitutions at all three threonine sites (Thr2605,
Thr2634, and Thr2643) of the targeted allele were confirmed by
sequencing DNA isolated from tails of heterozygotic (DNAPKcs+/3A) carriers. The sequencing profile showed equal detection of A from the wild-type allele and G from the targeted allele
at all three mutated positions (Fig. S1 A). The 3A substitution and
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The DNA-dependent protein kinase (DNA-PK) consists
of the large catalytic subunit (DNA-PK catalytic subunit
[DNA-PKcs]) and the DNA-binding Ku70/80 heterodimer. The
DSB is initially recognized by DNA-PK. The ends are then
synapsed and processed by other NHEJ proteins, including
Artemis, XLF, and XRCC4, before they are ligated together by
ligase IV (Weterings and Chen, 2008). DNA-PKcs belongs to a
serine/threonine protein kinase family known as the phosphatidylinositol-3 kinase–like protein kinases. Family members
include ataxia telangiectasia mutated (ATM) and ATM- and
Rad3-related (ATR) kinases (Shiloh, 2003). DNA-PKcs, itself,
is essential for NHEJ-mediated DSB repair, and loss of the
DNA-PKcs protein leads to radiation hypersensitivity as well as
severe combined immunodeficiency (SCID) caused by a block
in V(D)J recombination. In addition, DNA-PKcs deficiency results in a defect in immunoglobulin class switch recombination
(Manis et al., 2002; Cook et al., 2003; Callén et al., 2009).
DNA-PKcs is phosphorylated in several regions in vitro upon
activation and in vivo upon treatment with IR (Chan et al., 2002;
Douglas et al., 2002; Chen et al., 2005; Ma et al., 2005; Meek
et al., 2007). IR-induced Ser2056 phosphorylation is mediated
by DNA-PKcs autophosphorylation, as it is significantly reduced in a kinase-dead mutant DNA-PKcs and is inhibited by
the DNA-PKcs kinase inhibitor (Chen et al., 2005). In contrast,
DNA-PKcs phosphorylation at the Thr2609 cluster is dependent on ATM and ATR kinases in response to IR and UV radiation, respectively (Yajima et al., 2006; Chen et al., 2007).
DNA-PKcs phosphorylation at either the Thr2609 cluster or at
Ser2056 does not affect its kinase activity; nevertheless, abrogation of DNA-PKcs phosphorylation at either region attenuates
DSB repair and leads to increased radiosensitivity (Chan et al.,
2002; Ding et al., 2003; Chen et al., 2005, 2007).
To gain insight into the physiological significance of phosphorylation at this cluster, we have generated a 3A knockin
mouse model, in which the three threonine residues are substituted with alanines. In this study, we report that DNA-PKcs3A/3A
mice surprisingly develop congenital hematopoietic failure
caused by rapid loss of hematopoietic stem cells (HSCs) in the
developing fetal liver. This severe hematopoietic phenotype was
attributed to a compound deficiency in DSB repair, including the
HR and Fanconi anemia (FA) pathways. Because being defective
in NHEJ alone does not block HSC expansion in the embryo, we
conclude that the HR/FA pathways are essential for HSC development and that DNA-PKcs phosphorylation at the Thr2609
cluster is a prerequisite for the pathway switch favoring HR/FA.
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the one remaining loxP site between exon 58 and exon 59 did
not affect the expression of the 3A mutant DNA-PKcs from the
targeted allele, as similar levels of the DNA-PKcs protein were
detected in mouse embryonic fibroblasts (MEFs) derived from
all genotypes (Fig. 1 C). The 3A substitution also did not affect
the kinase activity of DNA-PKcs (Fig. S1 D) as previously
reported (Ding et al., 2003; Chen et al., 2007). Nonetheless,
clonogenic survival analysis revealed that DNA-PKcs3A/3A MEFs
were hypersensitive to IR to a similar degree as DNA-PKcs–null
MEFs (Fig. 1 D).
Complete disruption of the mouse DNA-PKcs gene results
in an SCID phenotype (Gao et al., 1998; Taccioli et al., 1998;
Kurimasa et al., 1999), but in contrast to Ku-deficient mice,
there is no apparent growth retardation, infertility, or life shortening in DNA-PKcs/ mice (Nussenzweig et al., 1996; Gu
et al., 1997; Ouyang et al., 1997). Homozygous DNA-PKcs3A/3A
mice were born at the expected Mendelian frequency with similar body weight to littermates, but they became apparently
smaller within 2–3 wk of age (Fig. S1 C). In striking contrast to
the normal life span of control, heterozygous littermates, and
DNA-PKcs/ mice, the great majority of DNA-PKcs3A/3A mice
died shortly after birth (Fig. 1 E). In a cohort of 56 DNA-PKcs3A/3A
mice, 75% died within 4 wk of birth, and only one mouse survived >12 wk.
Lymphocyte hypoplasia and the
V(D)J recombination defect in
DNA-PKcs3A/3A mice

Lymphocyte development in DNA-PKcs–null mice is severely
compromised because of a block in V(D)J recombination
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Figure 2. Lymphocyte development in DNA-PKcs3A/3A
mice. (A) T and B cell numbers are drastically reduced
in 2-wk-old DNA-PKcs3A/3A mice. n = 4. Error bars represent SD. (B) Flow cytometric analysis of thymocytes
from 2-wk-old mice. Similar to wild-type cells, the majority of DNA-PKcs3A/3A thymocytes were double positive
(CD4+CD8+). However, single-positive cell, particularly
CD4+CD8, thymocytes were reduced in DNA-PKcs3A/3A
mice. (C) Flow cytometric analysis of splenocytes from
2-wk-old mice. Single-positive CD4+CD8 and CD4CD8+
T cells were present in the DNA-PKcs3A/3A spleen, but
the numbers were also reduced. The numbers indicate the percentages of cell counts to total population
in each quadrant. The lines separate the negative and
the positive cell populations in each FACS analysis.
(D) Flow cytometric analysis of B lymphocyte development. B cell development in DNA-PKcs3A/3A mice was
arrested at the pro-B cell (B220lowCD43+IgM) stage with
very few mature B cells. Boxes indicate pro-B cell gate
(B220lowCD43+IgM); numbers indicate percentages
of cells in the gate to total population. (E) Analysis of
the mean number of junctional nucleotides lost in D2:
J1 coding joints cloned and sequenced from wild-type,
SCID, and DNA-PKcs3A/3A thymocytes. Means ± SEM are
plotted for each genotype. Results from two mice were
pooled for each genotype. Primary data are shown in
Table S1, Table S2, and Table S3. (F) Side scatter (SSC)
and forward scatter (FSC) signal of bone marrow (BM)
cells in flow cytometric analysis. Data show that, in the
DNA-PKcs3A/3A bone marrow, not only in the lymphoid (L)
gate but also in the granulocyte and macrophage (G/M)
gate, cell number dropped to a very low level compared
with wild-type and knockout (KO) mice.

(Gao et al., 1998; Taccioli et al., 1998; Kurimasa et al., 1999).
Like DNA-PKcs/ mice, the number of lymphocytes and the
size of lymphoid organs were drastically attenuated in 2-wk-old
DNA-PKcs3A/3A mice (Fig. 2 A and Fig. S2 A). In contrast to the
early T cell development block at the CD4CD8 double-negative
stage in DNA-PKcs–null mice (Gao et al., 1998; Kurimasa et al.,
1999), DNA-PKcs3A/3A mice have CD4+CD8+, CD4+CD8, and
CD4CD8+ thymocytes, although at significantly reduced
numbers (Fig. 2, A and B). Analyses of thymocyte subsets also
reveal a severe reduction of DNA-PKcs3A/3A double-negative
thymocytes at different developmental stages (Fig. S2 B).
Moreover, there is a significant reduction in the numbers of
T cells expressing TCR-/ (Fig. S2 C) and TCR- (Fig. S2 D),
which is observed in mice with mutations that cause a subtotal
block in V(D)J recombination (Difilippantonio et al., 2008).
Nevertheless, single-positive splenic T cells accumulated in the
DNA-PKcs3A/3A spleen (Fig. 2 C). B cell development in DNAPKcs3A/3A mice was also dramatically affected, with an apparent arrest at the B220lowCD43+IgM (pro-B cell) stage in bone
marrow and few mature B cells in the spleen (Fig. 2 D), which
is similar to the defective B cell development in DNA-PKcs/
mice (Gao et al., 1998; Taccioli et al., 1998; Kurimasa et al.,
1999). Significant loss of nucleotides is a hallmark of coding
joint formation in DNA-PKcs–deficient mice, and we find that
the extent of nucleotide loss during coding joint formation in
DNA-PKcs3A/3A thymocytes is similar to that observed in
DNA-PKcs–deficient (SCID) thymocytes (Fig. 2 E, Fig. S2 E,
Table S1, Table S2, and Table S3). Thus, phosphorylation
of the Thr2605 cluster in DNA-PKcs is required for normal
V(D)J recombination.
Hematopoietic failure in DNA-PKcs mutant mice • Zhang et al.
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Figure 3. Congenital bone marrow failure
and HSC/progenitor cell depletion in DNAPKcs3A/3A mice. (A) The averages of peripheral
blood WBC counts at day 1 (D1) and day 14
(D14) after birth (n = 4 for each group). (B) The
averages of RBC counts reveal the development of anemia in DNA-PKcs3A/3A mice after
birth (n = 4 for each group). (C) Bone marrow
was depleted in DNA-PKcs3A/3A mice. Bone
marrow was taken from one femur and one
tibia of 2-wk-old mice (n = 3 for each group).
Error bars represent SD. (D) Flow cytometric
analysis of HSC-enriched LSK cells. Bone marrow cells were stained with a lineage marker
cocktail, c-Kit, and Sca-1. LSK cells (LinSca1+c-Kit+) and myeloid progenitor cells (LinSca1c-Kit+) were ablated in 2-wk-old (day 14)
DNA-PKcs3A/3A mice. In newborn mice (day 1),
myeloid progenitor cells were detected. Boxes
indicate the LSK cell gate (LinSca-1+c-Kit+).
(E) Quantification of flow cytometric analysis
of HSCs (n ≥ 3 for each group). Lines indicate
the means for each group.

3A/3A

loss in DNA-PKcs

mice

Although lymphocyte development is compromised in DNAPKcs3A/3A mice, this would not be expected to cause early postnatal lethality in DNA-PKcs3A/3A mice, as SCID mice live a
normal life span. Examination of forward angle versus side
angle light scatter plots in bone marrow revealed not only a depletion of cells in the lymphocyte gate (as in SCID mice) but also
a lack of cells in the granulocyte and macrophage gate in DNAPKcs3A/3A bone marrow with a characteristically high level of
side scatter, suggesting a more general loss of leukocytes (Fig. 2 F).
During our investigation, we noticed that the ears, paws, and
internal organs of DNA-PKcs3A/3A mice were pale, suggesting the
development of anemia. A complete peripheral blood cell count
in 2-wk-old mice revealed a significant reduction in the numbers of WBCs, RBCs, and platelets in DNA-PKcs3A/3A mice,
suggesting the development of multilineage peripheral blood
cytopenia (Table S4). Analysis of peripheral blood samples
taken at different time points showed that pancytopenia in DNAPKcs3A/3A mice began 2 wk after birth and worsened with age
(Fig. 3, A and B). Consistent with the pancytopenia phenotype,
the average number of bone marrow–nucleated cells in 2-wkold DNA-PKcs3A/3A mice was significantly reduced (Fig. 3 C).
These results suggest that depletion of bone marrow–nucleated
cells in DNA-PKcs3A/3A mice leads to pancytopenia, which has
not been observed in DNA-PKcs/ or SCID mice.
Peripheral blood cells are continuously replenished from
HSC pools in hematopoietic organs, particularly in postnatal
bone marrow (Kondo et al., 2003). To examine whether a defect
in HSC homeostasis was the cause of bone marrow depletion in
DNA-PKcs3A/3A mice, a population of bone marrow HSCs
(LinSca-1+c-Kit+, hereafter referred to as LSK cells) was evaluated by flow cytometric analysis (Morrison et al., 1995). The
experiments revealed that bone marrow LSK cells and their derivative LinSca-1c-Kit+ progenitor cells were almost ablated
in 2-wk-old DNA-PKcs3A/3A mice and were 100 times less than
wild type even at day 1 (Fig. 3, D and E), whereas no significant
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difference was found in wild type, DNA-PKcs+/3A mice (Fig. 3 E),
or in DNA-PKcs/ mice (Fig. 3 D). These results demonstrate
that there is an impaired maintenance or self-renewal of bone
marrow HSCs in DNA-PKcs3A/3A mice and that the initiation
of HSC pathogenesis occurs during embryonic development.
Importantly, this dramatic early HSC failure has not been observed in other NHEJ-deficient mouse strains, in which HSC
reserves are generally preserved in young mice (Nijnik et al.,
2007; Rossi et al., 2007).
Fetal liver HSC dysfunction and loss in
DNA-PKcs3A/3A mice

The fetal liver is known to be the main source of hematopoiesis
during embryonic development, as it provides supportive niches
for HSC expansion and maturation (Mikkola and Orkin, 2006).
To determine when HSC homeostasis dysfunction occurred in
DNA-PKcs3A/3A embryos, fetal liver samples from different developmental stages were harvested and analyzed. Flow cytometric analysis revealed a decreased number of fetal liver LSK
cells in DNA-PKcs3A/3A embryos at embryonic day (E) 14.5
(0.08 ± 0.04% vs. wild type 0.19 ± 0.06%) and E.16.5 (0.05 ±
0.02% vs. wild type 0.14 ± 0.02%; Fig. 4, A and B). At E12.5,
the LSK cell population in DNA-PKcs3A/3A embryos was
slightly reduced (0.23 ± 0.10%) but remained within the normal range of wild-type embryos (0.26 ± 0.11%; Fig. 4 B). Significantly, the depletion of HSC reserves in the DNA-PKcs3A/3A
fetal liver occurs when HSCs are highly proliferative and
undergo rapid expansion (Mikkola and Orkin, 2006). To examine
whether the HSC loss in DNA-PKcs3A/3A mice was a result of
defective cell proliferation, freshly isolated fetal liver LSK
cells were cultured for ex vivo expansion. Wild-type and DNAPKcs+/3A LSK cells proliferated exponentially and continuously
during the course of ex vivo expansion, whereas DNA-PKcs3A/3A
LSK cells proliferated normally only in the first 24 h (Fig. 4 C).
The expansion of DNA-PKcs3A/3A LSK cells slowed down at 48 h
and then collapsed at 72 h as a result of massive cell death (unpublished data).
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Bone marrow transplantation rescues
DNA-PKcs3A/3A mice

Defective HSC expansion in fetal liver and depletion of nucleated cells in postnatal bone marrow suggest that HSC failure
might be the cause of early lethality in DNA-PKcs3A/3A mice. To
test this hypothesis, bone marrow transplantation (BMT) was
performed in 2-wk-old DNA-PKcs3A/3A–recipient mice using
wild-type littermates as donors. BMT was performed without
preconditioning procedures because DNA-PKcs3A/3A mice are
highly sensitive to radiation treatment (unpublished data) and
are immunoincompetent. After transplantation with wild-type
bone marrow cells, DNA-PKcs3A/3A recipients had an 80% survival rate at 2 mo and 60% at 1 yr (Fig. 4 D). BMT-rescued
DNA-PKcs3A/3A mice gained weight normally compared with
their heterozygotic littermates (Fig. S3 B). 8 wk after transplantation, peripheral blood cell counts in recipient mice showed a
complete recovery from pancytopenia and the restoration of the
bone marrow HSC pool (Fig. S3 A). Importantly, PCR genotyping revealed that hematopoietic organs in DNA-PKcs3A/3A
recipients were reconstituted primarily by wild-type donor cells
(Fig. 4 E), indicating a successful hematopoietic reconstitution.
The rescue of DNA-PKcs3A/3A mice could also be achieved by
transplantation with bone marrow LSK cells from wild-type
littermates with a reduced efficiency (Fig. 4 D), as the LSK faction primarily contains the upstream HSCs. In contrast, bone
marrow contains HSCs, progenitors, and partially differentiated
progenitors for different hematopoietic lineages and is able to
achieve a significant rescue within a shorter window of opportunity than LSKs.
The success of BMT rescue confirmed that HSC failure is
the main cause of early lethality in DNA-PKcs3A/3A mice. To determine whether there is an intrinsic defect of DNA-PKcs3A/3A
HSC proliferation in vivo, competitive repopulating assays were
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Figure 4. Loss of fetal liver HSCs in DNA-PKcs3A/3A
embryos. (A) Flow cytometric analysis of HSC-enriched LSK
cells in the E16.5 fetal liver. Percentages of LSKs are indicated. Boxes indicate the LSK cell gate (LinSca-1+c-Kit+).
(B) Quantitative analysis of fetal liver LSKs. Data show
progressive LSK loss in DNA-PKcs3A/3A embryos (one dot
represents one sample; at least four samples from one
time point were analyzed for each genotype). Lines indicate the means for each group. (C) Ex vivo expansion of
E13.5 fetal liver LSK cells. DNA-PKcs3A/3A LSKs showed
limited proliferation capacity compared with wild-type
and DNA-PKcs+/3A LSKs. (n = 3 for each group). (D) Kaplan–
Meier survival curves for untreated DNA-PKcs3A/3A
mice, bone marrow–transplanted (BMT) DNA-PKcs3A/3A
mice, and LSK cell–transplanted DNA-PKcs3A/3A mice
(*, P < 0.05; **, P < 0.001; log-rank test). (E) Hematopoietic reconstitution in DNA-PKcs3A/3A BMT mice by donor
cells. DNA samples from the thymus (T), spleen (S), and
bone marrow (B) of DNA-PKcs3A/3A BMT mice were PCR
genotyped. Wild-type PCR products were predominantly
presented in all three tissues. The asterisk denotes a
517-bp band of the 1-kb DNA ladder (Invitrogen).
(F) Competitive repopulation assay using E13.5 fetal liver
cells. DNA-PKcs3A/3A HSCs (CD45.1CD45.2+) failed to
repopulate in lethally irradiated B6-LY5.2/Cr host mice
(CD45.1+CD45.2). n = 4. (G) Competitive repopulation
was performed using bone marrow cells from 8-mo-old
DNA-PKcs/ and age-matched wild-type mice. DNAPKcs/ HSCs (CD45.1CD45.2+) showed reduced repopulating potential. n = 4. Error bars represent SD.

performed in irradiated CD45.1-recipient mice transplanted
with fetal liver LSK cells from wild-type or DNA-PKcs3A/3A
embryos (CD45.2 background) as well as the competing wild-type
CD45.1 bone marrow cells. As shown in Fig. 4 F, DNA-PKcs3A/3A
fetal liver LSKs were completely unable to repopulate in vivo,
demonstrating the severity of hematopoietic impairment in
DNA-PKcs3A/3A mice. In contrast, bone marrow cells from
8-mo-old DNA-PKcs/ mice retained the reconstitution ability, though with a reduced potential compared with age-matched
wild-type bone marrow cells (Fig. 4 G), suggesting a possible
age-associated defect in hematopoiesis in DNA-PKcs/ mice
as also observed in other NHEJ-defective mice (Nijnik et al.,
2007; Rossi et al., 2007).
Increase of spontaneous DNA lesions
and apoptosis in DNA-PKcs3A/3A fetal
liver HSCs

Based on our results, we hypothesized that the 3A mutant DNAPKcs might interfere with endogenous DSB repair, resulting in
an increase of spontaneous DNA lesions and cell death. To investigate this possibility, freshly isolated LSK cells from E12.5
fetal livers were stained for -H2AX nuclear foci, a commonly
used surrogate marker of DSB formation. LSK cells isolated
from wild-type and heterozygotic embryos rarely displayed
-H2AX foci, and no more than five -H2AX foci were observed in individual wild-type cells, whereas the majority of
DNA-PKcs3A/3A LSK cells were positively stained with -H2AX,
and >30% contained more than five -H2AX foci (Fig. 5 A).
In addition, a single-cell comet assay performed under alkaline conditions also revealed that a significant portion of DNAPKcs3A/3A LSK cells contained the comet tail as compared
with that of wild-type and heterozygotic LSK cells (Fig. S4 A).
Consistent with the induction of spontaneous DNA lesions, an
Hematopoietic failure in DNA-PKcs mutant mice • Zhang et al.
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increase of Annexin V staining was also confirmed in freshly
isolated fetal liver LSK cells from DNA-PKcs3A/3A embryos
(Fig. 5 B), suggesting that HSC loss in DNA-PKcs3A/3A mice is
likely caused by excessive apoptotic cell death.
Loss of p53 mitigates the stem cell
failure and promotes survival in
DNA-PKcs3A/3A mice

To examine whether HSC loss is caused by p53-mediated apoptotic response, DNA-PKcs3A mice were crossed with p53-null
mutant mice. Loss of both p53 alleles doubled the life span of
homozygotic DNA-PKcs3A/3A mice (abbreviated as 3A; Fig. 5 C)
and restored long-term HSCs (LinSca-1+c-Kit+Flt3CD34) in
DNA-PKcs3A/3A mice (Fig. 5 D). Strikingly, loss of a single copy
of p53 also prolonged the survival of 3A/p53+/ mice. In a cohort
of 22 3A/p53+/ mice, 50% survived beyond 8 wk, which is
significantly longer (P < 0.001) than the survival of 3A mice.
Despite the enhanced survival, there was still a major depletion
of bone marrow stem cells in 3A/p53+/ mice. We estimate from
two femur bones that there are 4.2 × 103 LSK cells in 3A/p53+/
mice compared with 2.9 × 105 LSK cells in wild-type mice.
In addition to life-span extension, a p53-null mutation
also alleviated the developmental defect of lymphocytes in
DNA-PKcs3A/3A mice. Thymocyte cell numbers were partially
rescued (60% of wild-type mice) in 3A/p53/ mice but not in
3A/p53+/ mice (Fig. 5 E), and the distribution of CD4 versus
CD8 cells was normalized in 3A/p53/ thymocytes (Fig. S4 B).
The rescue of B cell development was also obvious, as the numbers of B cells in 3A/p53/ mice were completely normal in


300

JCB • VOLUME 193 • NUMBER 2 • 2011

bone marrow (Fig. 5 F) but restored to a lesser degree in the
spleen (Fig. 5 G). Furthermore, even with the loss of a single
p53 gene, the numbers of B cells were partially rescued. There
were very few B220+IgM+ mature B cells in the 3A/p53+/+ bone
marrow, but these cells were clearly detectable in 3A/p53/
mice (Fig. S4 C). Thus, in contrast to DNA-PKcs–deficient
SCID mice in which loss of p53 does not rescue B cell development (Nacht et al., 1996), there is partial rescue of B lymphocytes in 3A/p53/ mice. This also suggests that the V(D)J
recombination defect in DNA-PKcs3A/3A mice is less severe than
in the complete absence of DNA-PKcs.
Increase of genotoxic stress in the
intestinal crypt and epidermis

In addition to HSC loss, elevation of the p53-dependent genotoxic stress response in DNA-PKcs3A/3A mice was also evident
in the intestinal crypt and epidermis. The intestinal crypt is the
proliferation compartment and contains intestine stem cells,
which give rise to different intestine epithelial cells for intestinal homeostasis maintenance. Immunohistological analysis revealed that a significant increase of TUNEL-positive cells was
found in the intestinal crypt of DNA-PKcs3A/3A mice and that the
p53-null mutation alleviated the defect completely (Fig. 6 A). Skin
hyperpigmentation is another example of a p53-dependent
stress response (McGowan et al., 2008) and can be found in the
footpad and tail of DNA-PKcs3A/3A mice (Fig. 6, B and C). As
expected, the hyperpigmentation phenotype is completely reversed in 3A/p53/ mice. Footpad hyperpigmentation became
apparent in DNA-PKcs3A/3A mice as early as 1 wk after birth and
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Figure 5. Elevation of DNA damage and p53 signaling in
DNA-PKcs3A/3A mice. (A) -H2AX foci analysis with freshly
isolated E12.5 fetal liver LSK cells. Cells were grouped
into three categories based on the number of -H2AX foci:
negative (zero foci/cell), positive (one to five foci/cell),
and strong positive (more than five foci/cell). A total of
50 cells were randomly selected from each genotype for
analysis. Data represent two independent assays. Bar, 10 µm.
(B) Annexin V staining of freshly isolated LSKs from
E13.5 fetal livers (n ≥ 3 for each group). Lines indicate the
means for each group. (C) Kaplan–Meier survival curves
of DNA-PKcs3A/3A mice (abbreviated as 3A) in different
p53 genotype backgrounds. (D) Flow cytometric analysis
of bone marrow (BM) HSCs in 2-wk-old mice. HSC loss,
particularly long-term HSC (LinSca-1+c-Kit+Flt3CD34)
loss in DNA-PKcs3A/3A was completely rescued in the p53null background. (top) Boxes indicate the LSK cell gate
(LinSca-1+c-Kit+). (bottom) The numbers indicate the percentages of cell counts to total population in each quadrant. The lines separate the negative and the positive cell
populations in each FACS analysis. (E–G) Null mutation of
p53 rescues the numbers of T and B cells in DNA-PKcs3A/3A
mice. The numbers of thymocytes (E), bone marrow B cells
(F), and splenic B cells (G) were determined from 2-wk-old
wild-type mice as well as in DNA-PKcs3A/3A mice with different p53 genotypes (n ≥ 3 for each group). Error bars
represent SD.
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was further darkened with age. In contrast, there was no footpad
pigmentation in wild-type and heterozygotic pups, whereas
mild footpad pigmentation could also be found in older (>2 mo)
heterozygotic mice (unpublished data).
Hypersensitivity of DNA-PKcs3A/3A MEFs
to DNA cross-linking agents

DNA-PKcs3A/3A MEFs exhibit a similar radiosensitivity to
DNA-PKcs/ MEFs and defective V(D)J recombination, yet
only in DNA-PKcs3A/3A mice is there a block in hematopoiesis
and an activation of the p53 pathway. Thus, there are likely to be
defects in addition to impaired NHEJ. To test this possibility,
DNA-PKcs3A/3A MEFs were subjected to different DNA damage agents (Fig. 7 A and Fig. S5 A). Clonogenic survival analyses revealed that DNA-PKcs3A/3A MEFs displayed a greater
sensitivity toward replication stress inducers, including UV
irradiation, camptothecin, and mitomycin C (MMC; Fig. 7 A).
The most striking difference came from treatment with the DNA
cross-linking agent MMC, as clonogenic survival of DNAPKcs3A/3A MEFs was dramatically reduced, whereas hetero
zygotic MEFs and, importantly, DNA-PKcs/ MEFs were not
affected. Furthermore, MMC treatment induced a significant
increase in chromosome aberrations in DNA-PKcs3A/3A MEFs
(Fig. 7 B), among which radial structures were frequently observed (Fig. S5 B).
Hypersensitivity toward DNA cross-linking agents and
bone marrow failure are the hallmarks of the inherited human
disease FA. The repair of DNA interstrand cross-links is a complex process that involves the FA complex and the HR pathway
(Mirchandani and D’Andrea, 2006). To determine whether the
FA pathway was affected, we analyzed the induction of FANCD2
monoubiquitination in response to DNA damage. Immunoblotting
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Figure 6. Activation of p53 in the intestinal crypt and epidermis in DNAPKcs3A/3A mice. (A) Representative figures of a TUNEL assay. Increase of
TUNEL-positive apoptotic cells (red) in the DNA-PKcs3A/3A intestinal crypt
(outlined with dashed lines). Nuclei were counterstained with DAPI (blue).
Bar, 50 µm. (B) Skin hyperpigmentation is clearly distinguishable in the
DNA-PKcs3A/3A footpad and tail. (C) Hematoxylin and eosin staining of tail
skin section. Massive melanin accumulated in the DNA-PKcs3A/3A epidermis
and was abolished in a p53-null background. Bar, 20 µm.

revealed that FANCD2 monoubiquitination was attenuated in
DNA-PKcs3A/3A MEFs in response to IR and MMC (Fig. 7 C and
Fig. S5 D) but was not ablated as observed in FANCA/ MEFs
(Fig. S5 E). This attenuation is not likely caused by a reduced
S-phase population in DNA-PKcs3A/3A MEFs, as no clear difference exists in cell cycle redistribution between wild-type and
DNA-PKcs3A/3A MEFs (Fig. S5 C). Activated FANCD2 is recruited to chromatin and forms nuclear foci where it facilitates
HR and interstrand cross-link repair (Garcia-Higuera et al., 2001).
In response to IR treatment, FANCD2 foci formation was detected in wild-type cells as early as 20 min after irradiation
(unpublished data), and the percentage of cells with FANCD2
foci increases with time (Fig. 7 D). In contrast, FANCD2 foci in
DNA-PKcs3A/3A MEFs appeared with delayed kinetics, and the
percentage of cells with foci was 50% of wild-type MEFs at
various time points after IR. A similar defect was detected in the
formation of Rad51 nuclear foci (Fig. S5 F), a prerequisite of
HR-mediated DNA repair (Haaf et al., 1995). Formation of
Rad51 foci was attenuated in DNA-PKcs3A/3A MEFs but was enhanced in DNA-PKcs/ MEFs, which is likely because of the
elevation of HR activity in the absence of NHEJ (Allen et al.,
2002). Finally, we analyzed HR activity using the direct repeat
(DR)–GFP reporter approach (Pierce et al., 1999). MEFs with a
single integration of the DR-GFP reporter were transfected with
an ISceI- glucocorticoid receptor (GR)–RFP construct to induce
DSB formation and HR reaction (Soutoglou et al., 2007). Our
result revealed that HR activity was attenuated in DNA-PKcs3A/3A
MEFs, and a significant portion of ISceI-GR-RFP–expressing
(RFP+) DNA-PKcs3A/3A cells was GFP (no recombination) as
compared with wild-type MEFs (Fig. 7 E). In contrast, HR activity was further enhanced in DNA-PKcs/ MEFs because of a
lack of NHEJ activity. The negative impact of the DNA-PKcs3A
mutant on the HR/FA responses thus provides an explanation for
the phenotypical difference between DNA-PKcs3A/3A mice and
DNA-PKcs–null mice.

Discussion
The self-renewal property of HSCs and their ability to sustain
long-term hematopoiesis require that genome integrity is strictly
maintained (Kenyon and Gerson, 2007; Niedernhofer, 2008).
It is well characterized that hematopoietic cells are highly sensitive to radiation-induced DNA damage, and bone marrow aplasia
is one of main causes for radiation-induced lethality. A recent
study showed that HSCs, but not progenitor cells, are preferentially killed by radiation, suggesting that HSCs are among the
most sensitive cell types to DNA damage (Wang et al., 2006).
HSCs in DNA repair-deficient individuals are highly susceptible to various kinds of genotoxic stresses. Genetically modified
mouse models also revealed that defects in the DNA damage
response result in the dysfunction of HSC maintenance. Hematopoietic failure with an early development of bone marrow hypo
cellularity is manifested in mice with a hypomorphic mutation
of Rad50 (Rad50S/S; Bender et al., 2002) and mice knockout of
ERCC1, a key factor in nucleotide excision repair and interstrand cross-link repair (Niedernhofer et al., 2004; Prasher et al.,
2005). Deficiency of ATM leads to elevated levels of oxidative
Hematopoietic failure in DNA-PKcs mutant mice • Zhang et al.
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stress and a progressive loss of the HSC pool with age (Ito
et al., 2004). Similarly, NHEJ deficiency in Ku80 knockout
mice diminishes HSC self-renewal capacity, whereas hypomorphic Lig4Y288C mice display an age-dependent decrease in
HSC numbers and bone marrow cellularity (Nijnik et al., 2007;
Rossi et al., 2007). In contrast, HSC loss in DNA-PKcs3A/3A
mice occurs significantly earlier during embryonic development, which resembles Rad50S/S and ERCC1/ models,
though it is not clear whether there is a functional overlap between the DNA-PKcs3A mutant protein and these two DNA repair factors in terms of HSC maintenance. On the other hand,
complete DNA-PKcs deficiency leads to a decrease in HSC
number (unpublished data) and repopulating ability in aged
DNA-PKcs knockout mice. The distinct phenotypes in HSC
maintenance between DNA-PKcs knockout and knockin mice
is likely a result of their difference in DSB repair capacity, as
DNA-PKcs3A/3A cells are also defective in the HR/FA responses
in addition to the diminished NHEJ activity. Thus, the combined deficiency in DSB repair renders DNA-PKcs3A/3A cells
hypersensitive to MMC and other replication stress agents. It is
conceivable that the HR/FA mechanism, but not the NHEJ, is
essential for replication-associated DNA damage repair and is
critical for the rapid expansion of HSC populations in developing fetal liver.
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DSBs are among the most dangerous types of DNA lesions
and pose a great challenge to cellular survival and genome
integrity maintenance. Multiple repair mechanisms, including
NHEJ, HR, and additional backup pathways, have evolved to
ensure that DSBs are promptly and properly eliminated from
the genome. Outside V(D)J recombination events, endogenous
DSBs occur primarily in the cycling cells though the conversion of
single-strand lesions during replication (Vilenchik and Knudson,
2003). From the standpoint of endogenous DSB production,
we could assume that DNA-PK and its downstream NHEJ
pathway, which is the predominant DSB repair mechanism in
mammalian cells and is operational in all cell cycle phases, have
a greater involvement in the replication-associated DNA damage
response than we previously thought. However, it is not clear
how DNA-PKcs and other factors of DSB repair are coordinated in response to replicative stresses, particularly in the
highly proliferative cell population. Our unexpected findings
from the DNA-PKcs3A mouse model provide strong evidence
that the impact of DNA-PKcs, particularly its phosphorylation at
the mouse Thr2605 cluster (human Thr2609), has a role beyond
the NHEJ mechanism.
It recently became clear that the competition between the
NHEJ and the HR/FA pathway has important biological significance. For example, loss of the NHEJ factor 53BP1 alleviates
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Figure 7. Defect in multiple DNA repair pathways in DNAPKcs3A/3A cells. (A) Clonogenic survival of SV40-transformed
MEFs after UV irradiation, camptothecin (CPT), and mito
mycin C (MMC). Representative data of three independent assays are shown. (B) Increase of MMC-induced chromosomal
aberrations in DNA-PKcs3A/3A MEFs from two independent
experiments. (left) Percentages of MEFs harboring chromosomal aberrations with or without MMC treatment. (right)
The average numbers of chromosome (Chre.) or chromatid
(Chtid.) breaks and chromosomal fusions were calculated
from ≥50 mitotic spreads of each genotype. (C) FANCD2
monoubiquitination after IR treatment. Primary MEF cultures
were subjected to 10 Gy of -ray and were harvested at
the indicated time points for Western blotting. The ratios
between mono- (L) and unubiquitinated (S) FANCD2 are
shown. (D) FANCD2 nuclear foci formation after IR (5 Gy)
treatment. Percentages of FANCD2 foci-positive cells (more
than five foci) at different time points were analyzed from
two independent assays. Greater than 200 cells were
counted for each time point and genotype. (E) Measurement
of HR with a DR-GFP assay. MEFs with a single copy of the
DR-GFP HR reporter were mock transfected or transfected
with the ISceI-GR-RFP plasmid and were analyzed at 24 h.
Lines divided the cells into three populations. The bottom
left cell population is negative for both RFP and GFP; the
bottom right cell population is only RFP positive. The top cell
population is positive for both RFP and GFP. The numbers
indicate percentages of cells in each gate. Recombination
was determined by the fraction of GFP+ cells among all
GFP+ and RFP+ cells. Each point represents data from three
individual clones. Error bars represent SD.
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to the loss of stem cells in bone marrow (Kennedy and D’Andrea,
2005; Rani et al., 2008). It is interesting to note that the human
dyskeratosis congenita syndrome, which is caused by telomerase
mutations, also displays bone marrow failure and hyper skin pigmentation characters. Conversely, mice with combined mutations
on telomerase and Pot1b, a component of the telomere-protecting
shelterin complex, exhibit dyskeratosis congenita–like characteristics, including bone marrow failure and footpad hyperpigmentation (Hockemeyer et al., 2008; He et al., 2009). This similarity
to DNA-PKcs3A/3A mice suggests a common stress response
among different congenital bone marrow failure diseases and warrants further investigation of DNA-PKcs phosphorylation on
telomere maintenance.

Materials and methods
Construction of the targeting vector and generation of DNA-PKcs3A/3A
knockin mice
The 3A knockin targeting vector was constructed using a previously described
self-excision gene-targeting approach (Bunting et al., 1999). The DNA-PKcs3A
mice were maintained in the mixed genetic background of 129× C57BL/6
and were bred with p53-null mice in an FVB background. ES cell targeting
and generation of chimeric mice were performed at the transgenic core facility
at the University of Texas Southwestern Medical Center. All animal experimental protocols were approved by the Animal Care Committee of the University
of Texas Southwestern Medical Center.
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the hypersensitivity of HR-defective Brca1 mutant cells to
DNA-damaging agents and restores DSB repair by HR (Bouwman
et al., 2010; Bunting et al., 2010). In addition, the FA pathway
plays a critical role in eliminating toxic NHEJ; suppression of
NHEJ alleviates the sensitivity of FA mutant cells to DNA crosslinking agents and facilitates error-free repair by HR (Adamo
et al., 2010; Pace et al., 2010). Similarly, our data suggest that
the DNA-PKcs3A mutant protein interferes with the HR pathway, which could explain the sensitivity to replication damage
and the severity of hematopoietic failure.
We have previously reported that the human Thr2609 cluster
is phosphorylated directly by the ATR kinase upon replication
stress (Yajima et al., 2006). This ATR-dependent DNA-PKcs
phosphorylation virtually facilitates processing of replicationassociated DNA lesions through the HR/FA machinery. It is likely
that, in such a repair process, the shift from error-prone end joining
to faithful repair by the HR/FA is partially achieved by ATRdependent DNA-PKcs phosphorylation. In support of this, a similar stem cell defect was observed in conditional ATR knockout
mice (Ruzankina et al., 2007). It is not clear yet how DNA-PKcs
phosphorylation at the Thr2609 cluster promotes HR/FA activities.
One possible explanation is that Thr2609 cluster phosphorylation
changes the conformation of DSB-bound DNA-PKcs and releases
DSB ends to the HR/FA machineries (Meek et al., 2008).
The loss of HSCs in DNA-PKcs3A/3A mice is primarily
caused by p53-mediated apoptotic response, as the p53-null
mutation reinstates HSC reserves in DNA-PKcs3A/3A mice. In
addition to HSC loss, elevation of genotoxic stress and p53 activation was found in other proliferating tissues as evident from
intestinal crypt cell apoptosis and epidermal hyperpigmentation. These results reiterate that DNA-PKcs phosphorylation at
the human Thr2609/mouse Thr2605 cluster is critical for replication stress response and the maintenance of tissue homeostasis. The tissue-specific outcome of genotoxic stress imposed by
the DNA-PKcs3A mutant protein or DNA-PKcs dysfunction
may depend on cell type–specific apoptosis/senescence and the
compensation capacity from varied sizes of stem cell pools in
different tissues and organs.
Gene mutations in the FA protein complex and HR components have been indentified in human FA syndrome characterized by congenital bone marrow failure, short stature, abnormal
skin pigmentation, reduced fertility, hypersensitivity toward DNA
cross-link damages, and increased genomic instability (Moldovan
and D’Andrea, 2009). The mechanism underlying the clinical
findings of FA remains unclear, given the fact that none of the
current mouse models for HR and FA systematically recapitulated these pathophysiological changes. It is interesting to note
that the DNA-PKcs3A/3A mouse resembles human FA syndromes
more than FA mouse models. The hallmarks of FA, including
aplastic anemia, abnormal skin pigmentation, MMC sensitivity,
and radial chromosome formation with MMC treatment, are all
observed in DNA-PKcs3A/3A mice, suggesting that, in human patients, FA mutations also likely affect the stem cell compartment
during embryo development and activate p53, which generates
pathological changes in multiple organs. Indeed, p53 has also
been shown to be up-regulated in FA cells, and it has been speculated that the p53-dependent apoptotic pathway may contribute

Clonogenic survival and chromosomal aberrations
Primary and SV40-transformed MEFs from E13.5 embryos were cultured in 
minimum essential medium supplemented with 10% fetal calf serum and penicillin/streptomycin. MEFs were maintained in a 37°C humidified atmosphere
with 3% O2 and 10% CO2. For clonogenic survival, SV40-transformed MEFs
were treated with different doses of mutagens and were trypsinized/reseeded
in appropriate numbers in 10-cm tissue-culture dishes for 7 d. For chromosomal aberrations, primary MEFs (passages 2–5) were incubated with
40 nM MMC for 24 h and 0.1 mg/ml colcemid in the last 2 h.
Fluorescence-activated cell sorting and ex vivo expansion of HSCs
Thymus, bone marrow, or fetal liver single-cell suspensions were stained
with the indicated antibodies and analyzed using either a FACSCalibur
(BD) or LSRII (BD) flow cytometer (Huynh et al., 2008). HSCs were sorted
using a flow cytometer (FACSAria; BD) essentially as previously described
(Huynh et al., 2008). For apoptosis analysis, cell suspensions were stained
with phycoerythrin-anti–Annexin V (BD). Ex vivo expansion of fetal liver
HSCs was performed using a previously published protocol (Zhang and
Lodish, 2004).
V(D)J recombination assay
D2:J1 coding joint junctions were PCR amplified from total thymocyte
DNA using a nested amplification protocol. The PCR conditions and primer
design are detailed in Fig. S2.
Bone marrow/HSC transplantation and competitive repopulating assay
Total bone marrow cells (5 × 105) or LinSca-1+c-Kit+ cells (1,500–5,000)
from wild-type littermates were injected into the retro-orbital plexus of 2- or
3-wk-old DNA-PKcs3A/3A mice without preconditioning. Competitive repopu
lation was performed using wild-type, DNA-PKcs3A/3A, or DNA-PKcs/
cells (CD45.2 background), mixed with competitive bone marrow cells
from B6-LY5.2/Cr mice (CD45.1 background), and injected into lethally irradiated (5 Gy × 2) B6-LY5.2/Cr–recipient mice. 2 mo after injection,
populations of CD45.1+ and CD45.2+ peripheral blood cells were analyzed by flow cytometry.
DR-GFP HR assay
SV40-transformed MEFs with single-copy incorporation of the DR-GFP reporter (Pierce et al., 1999) were transfected with the ISceI-GR-RFP plasmid
(Addgene) and treated with 10 nM triamcinolone acetonide for 24 h followed by flow cytometry analysis. HR activities were determined by the
percentage of GFP+RFP+ double-positive cells among all ISceI-GR-RFP–
expressing (RFP+) cells.
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Online supplemental material
Fig. S1 shows a DNA-PKcs3A mouse model with three alanine substitutions
at the Thr2605 cluster of the endogenous DNA-PKcs gene. Fig. S2 shows
compromised lymphocyte development in DNA-PKcs3A/3A mice. Fig. S3
shows BMT rescue of hematopoietic defects in DNA-PKcs3A/3A mice. Fig. S4
shows spontaneous DNA damage and a p53 signaling pathway in DNAPKcs3A/3A cells. Fig. S5 shows DNA repair defects in DNA-PKcs3A/3A cells.
Table S1 shows D2:J1 coding joint junctions cloned and sequenced
from wild-type mice. Table S2 shows D2:J1 coding joint junctions
cloned and sequenced from DNA-PKcs–deficient SCID mice. Table S3
shows D2:J1 coding joint junctions cloned and sequenced from DNAPKcs3A/3A mice. Table S4 shows the peripheral blood cell count of 2-wk-old
mice. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.201009074/DC1.
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